These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32174305)

  • 1. Biomarkers of abnormally invasive placenta.
    Al-Khan A; Youssef YH; Feldman KM; Illsley NP; Remache Y; Alvarez-Perez J; Mannion C; Alvarez M; Zamudio S
    Placenta; 2020 Feb; 91():37-42. PubMed ID: 32174305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
    Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
    Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
    Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
    Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio.
    Zhang F; Gu M; Chen P; Wan S; Zhou Q; Lu Y; Li L
    Placenta; 2022 Jun; 124():48-54. PubMed ID: 35635854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.
    Mitchell MI; Khalil M; Ben-Dov IZ; Alverez-Perez J; Illsley NP; Zamudio S; Al-Khan A; Loudig O
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
    Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta Accreta Spectrum Without Placenta Previa.
    Carusi DA; Fox KA; Lyell DJ; Perlman NC; Aalipour S; Einerson BD; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2020 Sep; 136(3):458-465. PubMed ID: 32769646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.
    Faraji A; Akbarzadeh-Jahromi M; Bahrami S; Gharamani S; Raeisi Shahraki H; Kasraeian M; Vafaei H; Zare M; Asadi N
    J Obstet Gynaecol; 2022 Jul; 42(5):900-905. PubMed ID: 34558384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Ultrasound Predictors of Placenta Accreta in Pregnant Women with Antepartum Diagnosis of Placenta Previa: A Multicenter Study.
    De Vita D; Capobianco G; Gerosolima G; Sciorio C; Coppola E; Parazzini F; Silvestri M; Caruso AP; Morlando M; Petta R; Pascarella A; Dessole S; Viora E
    Gynecol Obstet Invest; 2019; 84(3):242-247. PubMed ID: 30448828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycosylated hCG and Placenta Accreta Spectrum.
    Einerson BD; Straubhar A; Soisson S; Szczotka K; Dodson MK; Silver RM; Soisson AP
    Am J Perinatol; 2019 Jan; 36(1):22-26. PubMed ID: 29490399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
    Wang N; Shi D; Li N; Qi H
    Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation.
    Thompson O; Otigbah C; Nnochiri A; Sumithran E; Spencer K
    BJOG; 2015 Sep; 122(10):1370-6. PubMed ID: 25639820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?
    Li J; Zhang N; Zhang Y; Hu X; Gao G; Ye Y; Peng W; Zhou J
    Gynecol Endocrinol; 2019 Jul; 35(7):631-634. PubMed ID: 30784325
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa.
    Farisoğullari N; Tanaçan A; Sakcak B; Denizli R; Baştemur AG; Başaran E; Kara Ö; Yazihan N; Şahin D
    Cytokine; 2024 Apr; 176():156513. PubMed ID: 38262117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal deaths in Japan due to abnormally invasive placenta.
    Hasegawa J; Tanaka H; Katsuragi S; Sekizawa A; Ishiwata I; Ikeda T;
    Int J Gynaecol Obstet; 2018 Mar; 140(3):375-376. PubMed ID: 29080305
    [No Abstract]   [Full Text] [Related]  

  • 16. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study.
    Samuel A; Bonanno C; Oliphant A; Batey A; Wright JD
    Prenat Diagn; 2013 Nov; 33(11):1050-3. PubMed ID: 23836321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course.
    Sumigama S; Itakura A; Ota T; Okada M; Kotani T; Hayakawa H; Yoshida K; Ishikawa K; Hayashi K; Kurauchi O; Yamada S; Nakamura H; Matsusawa K; Sakakibara K; Ito M; Kawai M; Kikkawa F
    J Obstet Gynaecol Res; 2007 Oct; 33(5):606-11. PubMed ID: 17845316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association between Placenta Accreta Spectrum Severity and Incidence of Small for Gestational Age Neonates.
    Detlefs SE; Carusi DA; Modest AM; Einerson BD; Lyell D; Grace MR; Shrivastava VK; Khandelwal M; Salmanian B; Shainker SA; Fox KA; Subramaniam A; Crosland A; Duryea EL; Shamshirsaz AA; Shrestha K; Belfort MA; Silver RM; Clark SL; Shamshirsaz AA
    Am J Perinatol; 2023 Jan; 40(1):9-14. PubMed ID: 36096136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.